Page last updated: 2024-08-25

zoledronic acid and Ache

zoledronic acid has been researched along with Ache in 90 studies

Research

Studies (90)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	48 (53.33)	29.6817
2010's	28 (31.11)	24.3611
2020's	14 (15.56)	2.80

Authors

Authors	Studies
Cai, G; Jones, G; Laslett, LL; Zhang, X	1
Gao, P; Jiang, Y; Li, M; Wang, O; Xia, W; Xing, X; Yan, S; Zhang, Q; Zhang, Y	1
Flux, G; Liepe, K; Murray, I	1
Baumann, J; Genest, F; Heidemeier, A; Jakob, F; Meffert, R; Seefried, L	1
Cao, W; Dong, N; Hu, A; Qi, Y; Xiang, S; Xiao, J; Zhang, P; Zou, D	1
Chen, G; Hu, Q; Liu, F; Wang, Q; Yao, L; Zhang, L	1
Akazawa, K; Horiguchi, J; Ishikawa, T; Kaise, H; Kohno, N; Kubota, T; Machida, Y; Miura, D; Narui, K; Suzuki, M; Taguchi, T; Takao, S; Tawaraya, K; Yamada, K	1
McCadden, A; Miles, R; Min, K	1
Lopes, MG; McNaught, KA; Morris, JS; Tosi, G	1
Abate, V; Cavati, G; Falchetti, A; Gennari, L; Merlotti, D; Mingiano, C; Nuti, R; Rendina, D	1
Jacquier, C; Lafforgue, P; Laredo, JD; Larid, G; Pham, T; Valayer, S	1
Hong, BM; Hong, WW; Kim, IH; Mupparapu, M; Oak, S	1
Hald, JD; Javaid, MK; Keerie, C; Lam, W; Langdahl, BL; Osborne, P; Ralston, SH; Walsh, J; Weir, CJ	1
Kanri, Y; Kobayashi, E; Minami, Y; Ogawa, R; Ogura, I; Okada, Y; Ono, J; Tanaka, A	1
Ding, Y; Li, SX; Lin, H; Liu, X; Pei, FX; Xue, QY; Yin, F; Zeng, JC; Zhang, C; Zhang, CL; Zhang, Y	1
Moy, B; Somerfield, MR; Van Poznak, C	1
Aitken, D; Blizzard, L; Cai, G; Cicuttini, F; Hill, C; Jones, G; Laslett, LL; March, L; Wang, Y; Wluka, AE	1
Choi, J; Im, YR; Lee, EJ; Seong, J; Yang, SH	1
Ebbinghaus, M; Eitner, A; Hess, A; Hilger, I; Kamradt, T; Müller, S; Schaible, HG; Segond von Banchet, G; Wank, I	1
Bernstein, M; Fan, TM; Goldsby, RE; Gorlick, R; Isakoff, MS; Kim, G; Krailo, M; Lee, S; Marina, N; Meyer, J; Randall, RL; Villaluna, D; Wagner, LM	1
Body, JJ; Braun, A; Brown, JE; Chung, K; Cleeland, CS; Damyanov, D; Egerdie, B; Fallowfield, LJ; Marx, G; Palazzo, FG; Patrick, DL; Qian, Y; Stopeck, A; von Moos, R	1
Costa, L; Dansey, R; Feng, A; Henry, D; Hirsh, V; Hungria, V; Jun, S; Scagliotti, G; Smith, G; Vadhan-Raj, S; von Moos, R; Woll, PJ; Yeh, H	1
Levin, L; Luder, L	1
Chang, Y; Guo, G; He, X; Li, F; Li, L; Li, M; Su, D; Wang, W	1
Arellano, J; Bahl, A; Body, JJ; Gatta, F; Hauber, AB; Haynes, I; Hechmati, G; Mohamed, AF; Qian, Y; von Moos, R	1
Manabe, J; Miyata, S; Orita, Y; Sugitani, I; Takao, S; Toda, K	1
Gui, Q; Li, D; Xia, S; Xu, C; Yu, S; Zhuang, L	1
Beer, TM; Graff, JN	1
Body, JJ; Casimiro, S; Costa, L	1
Balakumaran, A; Body, JJ; Braun, A; Brown, J; Cleeland, C; Damyanov, D; Egerdie, B; Fallowfield, L; Marx, G; Palazzo, FS; Patrick, DL; Qian, Y; Stopeck, A; von Moos, R; Zhou, Y	1
Duan, Z; Fang, S; Giordano, SH; Goodwin, JS; Hortobagyi, GN; Kuo, YF	1
Abascal García, JM; Alcover García, J; Barreiro Mouro, A; Búcar Terrades, S; Carballido Rodriguez, J; Cózar Olmo, JM; Gálvez, R; Garcia-Galisteo, E; GómezVeiga, F; González Enguita, C; Jamardo Gonzalez, D; Luque Galvez, P; Medina López, RA; Minguez Martínez, RJ; Regadera Sejas, FJ; Rico Morales, M; Rodriguez Antolin, A; Sanchez Chapado, M; Sánchez Sánchez, E; Tabernero Gómez, AG	1
Alexakos, P; Christoulas, D; Konstantinidou, M; Terpos, E; Tsiftsakis, E; Voskaridou, E	1
Cheng, J; Wu, G; Wu, HG; Xue, J	1
Costa, L; Major, PP	1
Rotjanapan, P	1
Boutsikou, E; Eleftheriadou, E; Kanakis, I; Karamanos, NK; Kontakiotis, T; Lithoxopoulou, H; Tzanakakis, G; Zarogoulidis, K; Zarogoulidis, P	1
de Klerk, JM; Lam, MG; Zonnenberg, BA	1
Baziotis, N; Limouris, GS; Zafeirakis, A; Zissimopoulos, A	1
Boutrus, R; El-Attar, I; El-Hossieny, H; Kader, YA; Nazmy, M; Zaghloul, MS	1
Brown, JE; Coleman, RE; Cook, RJ; Costa, L; Lipton, A	1
Glasson, SS; Jian Li, X; Kennedy, JD; Leventhal, L; Mark, L; Piesla, MJ; Strassle, BW; Whiteside, GT	1
Arnold, RM; Weinstein, E	1
Van Poznak, C	1
Eastham, J; Saad, F	1
Archer, L; Burstein, HJ; Halabi, S; Hars, V; Hudis, C; Isaacs, C; Kirshner, J; Paskett, E; Schilsky, R; Shapiro, CL; Sikov, W; Weckstein, D; Winer, E	1
Drabick, J; Harvey, H; Lipton, A; Sivendran, S	1
Chen, YM; Costa, L; Hadji, P; Kosmidis, P; Lipton, A	1
Cao, L; Ding, HF; Liu, GW; Liu, S; Mao, YQ; Nie, SB; Wang, XQ; Yu, B; Yu, DG; Zhao, X; Zhu, ZA	1
Chung, K; Cleeland, CS; Fallowfield, LJ; Feng, A; Goldwasser, F; Henry, DH; Hungria, V; Novello, S; Patrick, DL; Qian, Y; Vadhan-Raj, S; von Moos, R; Yeh, H	1
Body, JJ; Braun, A; Chung, K; Cleeland, CS; Clemons, M; Dansey, R; de Boer, R; Fallowfield, L; Jiang, Q; Lipton, A; Masuda, N; Mathias, SD; Oliveira, CT; Patrick, DL; Qian, Y; Salvagni, S; Stopeck, A; Tonkin, K; von Moos, R	1
Gleason, D; Gordon, D; Kowalski, MO; Lipton, A; Reitsma, D; Rosen, L; Saad, F; Seaman, J; Small, E; Smith, M	1
Bowes, M; Chan, O; Fox, AJ; Glatt, M; Green, J; Kesingland, A; Kidd, BL; McNair, K; Medhurst, SJ; Patel, S; Urban, LA; Walker, K	1
Cook, R; Major, PP	1
Rosenthal, M	1
Atkins, CD	1
Heidenreich, A	1
Dearnaley, DP; Mason, MD; Moffat, LE; Naylor, SL; Parmar, MK; Powell, CS; Robinson, AC; Stott, M; Sydes, MR; Thompson, PM	1
Beer, TM; Garzotto, M; Tiffany, NM; Wersinger, EM	1
Ambler, G; Cowell, CT; Högler, W; Little, D; McQuade, M; Yap, F	1
Decker, JL; Henderson, C; Hohneker, JA; Kaplan, BH; Lacerna, L; Orlowski, R; Purdy, MH; Schnell, FM; Vogel, CL; Wood, AJ; Yanagihara, RH	1
Tanvetyanon, T	1
Antoniou, N; Bamias, A; Bozas, G; Deliveliotis, C; Dimopoulos, MA; Efstathiou, E; Kastritis, E; Kostakopoulos, A; Papadimitriou, C; Skarlos, D	1
Khuri, F; Saba, N	1
Brahmbhatt, V; Patel, K; Ramu, V	1
Barrett-Lee, P; Cameron, D; Davidson, N; Dodwell, D; Hong, A; Mansi, J; Mason, T; Murphy, R; Wardley, A	1
Saad, F	2
Lipton, A; Saad, F	1
Arcara, C; Badalamenti, G; Casuccio, A; Cicero, G; Di Fede, G; Fulfaro, F; Gebbia, N; Intrivici, C; Leto, G; Rini, GB; Russo, A; Valerio, MR; Vitale, A	1
Klain, M; Liuzzi, R; Marinelli, A; Molino, L; Pace, L; Paone, G; Salvatore, M; Soricelli, A; Storto, G	1
Baccarani, M; Boni, P; Cangini, D; Cavo, M; Ceccolini, M; Cellini, C; Parente, R; Perrone, G; Tacchetti, P; Tosi, P; Tura, S; Zamagni, E	1
Anstrom, KJ; Castel, LD; Saad, F; Schulman, KA; Weinfurt, KP	1
Ciccarelli, R; Fedele, S; Lo Muzio, L; Lo Russo, L; Mignogna, MD	1
Kaise, H; Kohno, N	1
Chamorey, E; Ciais, C; Ferrero, JM; Italiano, A; Largillier, R; Marcy, PY; Thyss, A	1
Clemons, MJ; Cole, DE; Dranitsaris, G; Ooi, WS; Pritchard, KI; Sukovic, T; Trudeau, M; Verma, S; Wong, BY; Yogendran, G	1
Furlow, B	1
Avanzati, A; De Paola, V; Gennari, L; Martini, G; Merlotti, D; Nuti, R; Valleggi, F	1
Addeo, R; Capasso, E; Caraglia, M; Cennamo, G; Del Prete, S; Faiola, V; Ferraro, G; Guarrasi, R; Montella, L; Nocera, V; Rossi, E; Santini, D; Tonini, G; Vincenzi, B	1
Maxwell, C	1
Major, P	1
Chen, YM; Chin, J; Gleason, DM; Saad, F	1
Kohno, N; Yamada, K	1
Friese, K; Janni, W; Rack, B; Schindlbeck, C; Sommer, H; Strobl, B	1
Badia, X; Chow, E; Costa, L; Lipton, A; Wardley, A	1
Andreu, FJ; Calvo, F; Casas, F; Ciria, JP; Contreras, J; de las Heras, M; Esco, R; Fuertes, J; López, C; Mañas, A; Márquez, M; Martín, C; Martínez, JC; Palacios, A; Pérez, L; Porto, C; Ramos, A; Romero, J; Sáez, J; Sánchez, E; Vayreda, J; Veiras, C; Victoria, C	1
Berenson, JR; Conde, F; Henick, K; Nishikubo, C; Rettig, M; Swift, RA; Vescio, R; Von Teichert, JM	1
Heatley, S	1

Reviews

18 review(s) available for zoledronic acid and Ache

Article	Year
Intravenous bisphosphonates do not improve knee pain or bone marrow lesions in people with knee osteoarthritis: a meta-analysis. Rheumatology (Oxford, England), 2022, 05-30, Volume: 61, Issue:6 Topics: Bone Marrow; Cartilage Diseases; Diphosphonates; Humans; Knee Joint; Osteoarthritis, Knee; Pain; Zoledronic Acid	2022
Dosimetry of Bone Seeking Beta Emitters for Bone Pain Palliation Metastases. Seminars in nuclear medicine, 2022, Volume: 52, Issue:2 Topics: Bone and Bones; Bone Neoplasms; Humans; Lutetium; Pain; Radiopharmaceuticals; Rhenium; Tissue Distribution; Zoledronic Acid	2022
Drug treatment strategies for paget's disease: relieving pain and preventing progression. Expert opinion on pharmacotherapy, 2023, Volume: 24, Issue:6 Topics: Bone Density Conservation Agents; Diphosphonates; Humans; Osteitis Deformans; Pain; Zoledronic Acid	2023
A Patient with a History of Multiple Myeloma Presents for the Evaluation of Oral Lesion and Burning Sensation of the Mouth. Dental clinics of North America, 2023, Volume: 67, Issue:4 Topics: Face; Humans; Mouth; Multiple Myeloma; Pain; Zoledronic Acid	2023
Reducing Skeletal-Related Events in Metastatic Castration-Resistant Prostate Cancer. Oncology (Williston Park, N.Y.), 2015, Volume: 29, Issue:6 Topics: Androgen Receptor Antagonists; Androstenes; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Benzamides; Bone Density Conservation Agents; Bone Neoplasms; Cost-Benefit Analysis; Denosumab; Diphosphonates; Enzyme Inhibitors; Fractures, Spontaneous; Humans; Imidazoles; Male; Nitriles; Pain; Phenylthiohydantoin; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radium; Spinal Cord Compression; Zoledronic Acid	2015
Targeting bone metastases in prostate cancer: improving clinical outcome. Nature reviews. Urology, 2015, Volume: 12, Issue:6 Topics: Antineoplastic Agents; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Drug Therapy, Combination; Humans; Imidazoles; Male; Osteoblasts; Osteolysis; Pain; Prognosis; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Radioisotopes; Radiopharmaceuticals; Radium; Treatment Outcome; Zoledronic Acid	2015
Effect of bisphosphonates on pain and quality of life in patients with bone metastases. Nature clinical practice. Oncology, 2009, Volume: 6, Issue:3 Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Pain; Palliative Care; Quality of Life; Treatment Outcome; Zoledronic Acid	2009
The new bisphosphonate, Zometa (zoledronic acid), decreases skeletal complications in both osteolytic and osteoblastic lesions: a comparison to pamidronate. Cancer investigation, 2002, Volume: 20 Suppl 2 Topics: Adenocarcinoma; Biomarkers; Bone Neoplasms; Breast Neoplasms; Clinical Trials as Topic; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Osteoblasts; Osteoclasts; Osteolysis; Osteoporosis; Pain; Pamidronate; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Safety; Zoledronic Acid	2002
Efficacy of bisphosphonates in the management of skeletal complications of bone metastases and selection of clinical endpoints. American journal of clinical oncology, 2002, Volume: 25, Issue:6 Suppl 1 Topics: Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Data Interpretation, Statistical; Diphosphonates; Female; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Male; Models, Statistical; Pain; Pamidronate; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Spinal Cord Compression; Treatment Outcome; Zoledronic Acid	2002
Bisphosphonates in the management of metastatic prostate cancer. Oncology, 2003, Volume: 65 Suppl 1 Topics: Antineoplastic Agents; Bone Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Humans; Ibandronic Acid; Imidazoles; Male; Pain; Palliative Care; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Treatment Outcome; Zoledronic Acid	2003
The role of bisphosphonates in the management of advanced cancer with a focus on non-small-cell lung cancer. Part 2: Clinical studies and economic analyses. Oncology, 2005, Volume: 68, Issue:1 Topics: Antineoplastic Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Cost-Benefit Analysis; Diphosphonates; Drug Costs; Fractures, Spontaneous; Humans; Hypercalcemia; Imidazoles; Lung Neoplasms; Multicenter Studies as Topic; Nerve Compression Syndromes; Pain; Spinal Cord Compression; United States; Zoledronic Acid	2005
Zoledronic acid is effective in preventing and delaying skeletal events in patients with bone metastases secondary to genitourinary cancers. BJU international, 2005, Volume: 96, Issue:7 Topics: Aged; Bone Neoplasms; Bone Resorption; Diphosphonates; Female; Humans; Imidazoles; Kidney Neoplasms; Male; Middle Aged; Pain; Prostatic Neoplasms; Zoledronic Acid	2005
[Bisphosphonates for bone metastasis of malignant tumor]. Clinical calcium, 2006, Volume: 16, Issue:4 Topics: Bone Neoplasms; Bone Resorption; Carrier Proteins; Clinical Trials as Topic; Cytokines; Diphosphonates; Evidence-Based Medicine; Humans; Imidazoles; Membrane Glycoproteins; Osteoclasts; Pain; Quality of Life; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Zoledronic Acid	2006
Optimal management of metastatic bone disease. European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2007, Volume: 11 Suppl 2 Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Drug Administration Schedule; Humans; Imidazoles; Incidence; Morbidity; Pain; Palliative Care; Patient Selection; Practice Guidelines as Topic; Quality of Life; Risk Factors; Risk Reduction Behavior; Treatment Outcome; Zoledronic Acid	2007
New research findings on zoledronic acid: survival, pain, and anti-tumour effects. Cancer treatment reviews, 2008, Volume: 34, Issue:2 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Resorption; Clinical Trials as Topic; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Male; Pain; Prostatic Neoplasms; Urogenital Neoplasms; Zoledronic Acid	2008
[Clinical study of bisphosphonates for bone metastasis in breast cancer]. Nihon rinsho. Japanese journal of clinical medicine, 2007, Nov-28, Volume: 65 Suppl 9 Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fractures, Bone; Humans; Imidazoles; Osteoclasts; Pain; Pamidronate; Quality of Life; Randomized Controlled Trials as Topic; Zoledronic Acid	2007
Impact of skeletal complications on patients' quality of life, mobility, and functional independence. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2008, Volume: 16, Issue:8 Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fractures, Bone; Health Status; Humans; Imidazoles; Male; Pain; Prostatic Neoplasms; Quality of Life; Zoledronic Acid	2008
Metastatic bone disease and tumour-induced hypercalcaemia: the role of bisphosphonates. International journal of palliative nursing, 2001, Volume: 7, Issue:6 Topics: Bone Neoplasms; Diphosphonates; Humans; Hypercalcemia; Imidazoles; Neoplasms; Pain; Zoledronic Acid	2001

Trials

36 trial(s) available for zoledronic acid and Ache

Article	Year
Efficacy of Zoledronic Acid in the Treatment of Nonmalignant Painful Bone Marrow Lesions: A Triple-Blind, Randomized, Placebo-Controlled Phase III Clinical Trial (ZoMARS). Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2022, Volume: 37, Issue:3 Topics: Bone Density; Bone Density Conservation Agents; Bone Marrow; Cartilage Diseases; Diphosphonates; Double-Blind Method; Humans; Pain; Vitamin D; Zoledronic Acid	2022
Combination of Calcitriol and Zoledronic Acid on PINP and Disease markers, 2022, Volume: 2022 Topics: Calcitriol; Diabetes Mellitus; Fractures, Avulsion; Humans; Osteoporosis; Pain; Tibial Fractures; Treatment Outcome; Zoledronic Acid	2022
Strontium-89 plus zoledronic acid versus zoledronic acid for patients with painful bone metastatic breast cancer. Journal of bone and mineral metabolism, 2022, Volume: 40, Issue:6 Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Pain; Quality of Life; Zoledronic Acid	2022
Protocol of a randomised trial of teriparatide followed by zoledronic acid to reduce fracture risk in adults with osteogenesis imperfecta. BMJ open, 2023, 11-22, Volume: 13, Issue:11 Topics: Adolescent; Adult; Bone Density; Bone Density Conservation Agents; Fractures, Bone; Humans; Osteogenesis Imperfecta; Pain; Quality of Life; Randomized Controlled Trials as Topic; Teriparatide; Zoledronic Acid	2023
A protocol for a multicentre, randomised, double-blind, placebo-controlled trial to compare the effect of annual infusions of zoledronic acid to placebo on knee structural change and knee pain over 24 months in knee osteoarthritis patients - ZAP2. BMC musculoskeletal disorders, 2018, Jul-18, Volume: 19, Issue:1 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Double-Blind Method; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Knee Joint; Male; Middle Aged; Osteoarthritis, Knee; Pain; Time Factors; Treatment Outcome; Zoledronic Acid	2018
A prospective Phase II study for the efficacy of radiotherapy in combination with zoledronic acid in treating painful bone metastases from gastrointestinal cancers. Journal of radiation research, 2019, Mar-01, Volume: 60, Issue:2 Topics: Adult; Aged; Biomarkers, Tumor; Bone Neoplasms; Chemoradiotherapy; Combined Modality Therapy; Female; Gastrointestinal Neoplasms; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pain; Prospective Studies; Quality of Life; Survival Analysis; Treatment Outcome; Zoledronic Acid	2019
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group. European journal of cancer (Oxford, England : 1990), 2013, Volume: 49, Issue:10 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Diphosphonates; Dose-Response Relationship, Drug; Drug Administration Schedule; Edema; Extremities; Feasibility Studies; Female; Humans; Hypokalemia; Hyponatremia; Hypophosphatemia; Imidazoles; Kaplan-Meier Estimate; Male; Mucositis; Neoplasm Metastasis; Osteosarcoma; Pain; Treatment Outcome; Young Adult; Zoledronic Acid	2013
Pain and health-related quality of life in patients with advanced solid tumours and bone metastases: integrated results from three randomized, double-blind studies of denosumab and zoledronic acid. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Analgesics; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Denosumab; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Male; Middle Aged; Neoplasms; Pain; Prostatic Neoplasms, Castration-Resistant; Quality of Life; Young Adult; Zoledronic Acid	2013
Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014, Volume: 22, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Denosumab; Diphosphonates; Disease Progression; Double-Blind Method; Female; Humans; Imidazoles; Kaplan-Meier Estimate; Male; Middle Aged; Multiple Myeloma; Neoplasms; Pain; Treatment Outcome; Zoledronic Acid	2014
An effective therapy to painful bone metastases: cryoablation combined with zoledronic acid. Pathology oncology research : POR, 2014, Volume: 20, Issue:4 Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Combined Modality Therapy; Cryosurgery; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Neoplasm Staging; Neoplasms; Pain; Prognosis; Prospective Studies; Zoledronic Acid	2014
Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2016, Volume: 24, Issue:3 Topics: Analgesics; Bone Neoplasms; Denosumab; Diphosphonates; Double-Blind Method; Female; Fractures, Spontaneous; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Pain; Zoledronic Acid	2016
[Effectiveness and tolerability of zoledronic acid in the treatment of metastatic prostate cancer]. Actas urologicas espanolas, 2008, Volume: 32, Issue:5 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Male; Pain; Prospective Studies; Prostatic Neoplasms; Zoledronic Acid	2008
Continuous improvement of bone mineral density two years post zoledronic acid discontinuation in patients with thalassemia-induced osteoporosis: long-term follow-up of a randomized, placebo-controlled trial. Haematologica, 2008, Volume: 93, Issue:10 Topics: Adult; Biomarkers; Bone Density; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Osteoporosis; Pain; Thalassemia; Time Factors; Zoledronic Acid	2008
[Clinical analysis of therapeutic effect of zoledronic acid combined with radiotherapy for metastatic bone cancer]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:7 Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Bone Regeneration; Breast Neoplasms; Combined Modality Therapy; Diphosphonates; Female; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Nasopharyngeal Neoplasms; Pain; Pain Management; Radiotherapy; Zoledronic Acid	2008
A prospective, randomized, placebo-controlled trial of zoledronic acid in bony metastatic bladder cancer. International journal of clinical oncology, 2010, Volume: 15, Issue:4 Topics: Adult; Aged; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Drug Administration Schedule; Egypt; Female; Fractures, Bone; Humans; Hypercalcemia; Imidazoles; Kaplan-Meier Estimate; Male; Middle Aged; Pain; Placebo Effect; Prospective Studies; Risk Assessment; Risk Factors; Spinal Cord Compression; Time Factors; Treatment Outcome; Urinary Bladder Neoplasms; Zoledronic Acid	2010
Zoledronic Acid improves clinical outcomes when administered before onset of bone pain in patients with prostate cancer. Urology, 2010, Volume: 76, Issue:5 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Male; Pain; Pain Measurement; Prostatic Neoplasms; Spinal Cord Compression; Survival Rate; Zoledronic Acid	2010
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. European journal of cancer (Oxford, England : 1990), 2011, Volume: 47, Issue:5 Topics: Adult; Antineoplastic Agents; Bone Density; Bone Density Conservation Agents; Breast Neoplasms; Chemotherapy, Adjuvant; Diphosphonates; Fatigue; Female; Fever; Humans; Imidazoles; Infusions, Intravenous; Middle Aged; Pain; Premenopause; Primary Ovarian Insufficiency; Prospective Studies; Zoledronic Acid	2011
Treatment of bone metastases before the onset of pain. International journal of clinical oncology, 2013, Volume: 18, Issue:3 Topics: Aged; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Lung Neoplasms; Male; Middle Aged; Neoplasm Staging; Pain; Randomized Controlled Trials as Topic; Zoledronic Acid	2013
Clinical benefit in patients with metastatic bone disease: results of a phase 3 study of denosumab versus zoledronic acid. Annals of oncology : official journal of the European Society for Medical Oncology, 2012, Volume: 23, Issue:12 Topics: Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Denosumab; Diphosphonates; Double-Blind Method; Humans; Imidazoles; Pain; Quality of Life; RANK Ligand; Treatment Outcome; Zoledronic Acid	2012
Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid. Cancer, 2013, Feb-15, Volume: 119, Issue:4 Topics: Analgesics; Antibodies, Monoclonal, Humanized; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Denosumab; Diphosphonates; Double-Blind Method; Female; Humans; Imidazoles; Middle Aged; Pain; Zoledronic Acid	2013
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. Journal of the National Cancer Institute, 2003, Feb-19, Volume: 95, Issue:4 Topics: Androgens; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Male; Pain; Prostatic Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome; Zoledronic Acid	2003
Re: A randomized, placebo-controlled trial of zoledronic acid in patients with hormone-refractory metastatic prostate carcinoma. Journal of the National Cancer Institute, 2003, Feb-19, Volume: 95, Issue:4 Topics: Androgens; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Male; Pain; Prostatic Neoplasms; Quality of Life; Randomized Controlled Trials as Topic; Treatment Outcome; Zoledronic Acid	2003
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer (MRC PR05 Trial). Journal of the National Cancer Institute, 2003, Sep-03, Volume: 95, Issue:17 Topics: Administration, Oral; Aged; Analgesics, Non-Narcotic; Androgen Antagonists; Antineoplastic Agents, Hormonal; Bone Neoplasms; Clodronic Acid; Digestive System; Diphosphonates; Disease-Free Survival; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Humans; Imidazoles; Male; Middle Aged; Odds Ratio; Pain; Prostatic Neoplasms; Research Design; Survival Analysis; Treatment Outcome; United Kingdom; Zoledronic Acid	2003
Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer. Urology, 2004, Volume: 63, Issue:5 Topics: Aged; Antineoplastic Agents; Benzamides; Bone Diseases; Bone Neoplasms; Bone Resorption; Diphosphonates; Disease Progression; Drug Therapy, Combination; Humans; Imatinib Mesylate; Imidazoles; Male; Middle Aged; Pain; Piperazines; Prostate-Specific Antigen; Prostatic Neoplasms; Pyrimidines; Treatment Failure; Zoledronic Acid	2004
Safety and pain palliation of zoledronic acid in patients with breast cancer, prostate cancer, or multiple myeloma who previously received bisphosphonate therapy. The oncologist, 2004, Volume: 9, Issue:6 Topics: Aged; Arthralgia; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Creatinine; Diphosphonates; Fatigue; Female; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Multiple Myeloma; Nausea; Pain; Pain Measurement; Prospective Studies; Prostatic Neoplasms; Quality of Life; Treatment Outcome; Zoledronic Acid	2004
Zoledronic acid significantly improves pain scores and quality of life in breast cancer patients with bone metastases: a randomised, crossover study of community vs hospital bisphosphonate administration. British journal of cancer, 2005, May-23, Volume: 92, Issue:10 Topics: Activities of Daily Living; Adult; Aged; Bone Neoplasms; Breast Neoplasms; Cross-Over Studies; Diphosphonates; Emotions; Female; Hospitals, Community; Humans; Imidazoles; Infusions, Intravenous; Inpatients; Middle Aged; Outpatients; Pain; Pain Measurement; Quality of Life; Zoledronic Acid	2005
Clinical benefit of zoledronic acid for the prevention of skeletal complications in advanced prostate cancer. Clinical prostate cancer, 2005, Volume: 4, Issue:1 Topics: Aged; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Incidence; Male; Pain; Prostatic Neoplasms; Quality of Life; Retrospective Studies; Spinal Cord Compression; Zoledronic Acid	2005
The use of zoledronic acid in patients with bone metastases from prostate carcinoma: effect on analgesic response and bone metabolism biomarkers. Journal of chemotherapy (Florence, Italy), 2005, Volume: 17, Issue:5 Topics: Aged; Biomarkers; Bone Density Conservation Agents; Bone Neoplasms; Bone Resorption; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Pain; Pain Measurement; Prostatic Neoplasms; Zoledronic Acid	2005
First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma. European journal of haematology, 2006, Volume: 76, Issue:5 Topics: Adult; Aged; Alkaline Phosphatase; Amino Acids; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bone Remodeling; Bone Resorption; Collagen Type I; Dexamethasone; Diphosphonates; Female; Humans; Imidazoles; Male; Middle Aged; Multiple Myeloma; Osteocalcin; Pain; Peptides; Thalidomide; Treatment Outcome; Zoledronic Acid	2006
Effect of zoledronic acid on pain associated with bone metastasis in patients with prostate cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:6 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Infusions, Intravenous; Male; Pain; Pain Measurement; Placebos; Prostatic Neoplasms; Zoledronic Acid	2006
Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Oct-20, Volume: 24, Issue:30 Topics: Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Clodronic Acid; Diphosphonates; Disease Progression; Drug Resistance; Female; Humans; Imidazoles; Middle Aged; Pain; Palliative Care; Pamidronate; Prospective Studies; Treatment Outcome; Zoledronic Acid	2006
Comparison of different intravenous bisphosphonate regimens for Paget's disease of bone. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2007, Volume: 22, Issue:10 Topics: Aged; Diphosphonates; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Imidazoles; Injections, Intravenous; Male; Osteitis Deformans; Pain; Pamidronate; Quality of Life; Time Factors; Zoledronic Acid	2007
Continuing benefit of zoledronic acid in preventing skeletal complications in patients with bone metastases. Clinical genitourinary cancer, 2007, Volume: 5, Issue:6 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Male; Pain; Prostatic Neoplasms; Retrospective Studies; Zoledronic Acid	2007
[Efficacy of zoledronate in treating persisting isolated tumor cells in bone marrow in patients with breast cancer. A phase II pilot study]. Deutsche medizinische Wochenschrift (1946), 2008, Volume: 133, Issue:7 Topics: Adult; Aged; Antineoplastic Agents; Bone Density Conservation Agents; Bone Marrow; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Combined Modality Therapy; Diphosphonates; Female; Humans; Imidazoles; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Hormone-Dependent; Pain; Pilot Projects; Prognosis; Zoledronic Acid	2008
Randomised study of single dose (8 Gy vs. 6 Gy) of analgesic radiotherapy plus zoledronic acid in patients with bone metastases. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2008, Volume: 10, Issue:5 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Dose-Response Relationship, Radiation; Female; Humans; Imidazoles; Male; Middle Aged; Pain; Pain Management; Pain Measurement; Quality of Life; Radiotherapy; Zoledronic Acid	2008
A Phase I, open label, dose ranging trial of intravenous bolus zoledronic acid, a novel bisphosphonate, in cancer patients with metastatic bone disease. Cancer, 2001, Jan-01, Volume: 91, Issue:1 Topics: Adult; Aged; Anorexia; Biomarkers; Bone Neoplasms; Bone Resorption; Constipation; Diphosphonates; Female; Fever; Humans; Imidazoles; Injections, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Pain; Treatment Outcome; Zoledronic Acid	2001

Other Studies

36 other study(ies) available for zoledronic acid and Ache

Article	Year
Clinical, Biochemical, Radiological, and Genetic Analyses of a Patient with VCP Gene Variant-Induced Paget's Disease of Bone. Calcified tissue international, 2022, Volume: 110, Issue:4 Topics: Female; Fractures, Compression; Frontotemporal Dementia; Humans; Muscular Diseases; Mutation; Osteitis Deformans; Pain; Profilins; Spinal Fractures; Valosin Containing Protein; Zoledronic Acid	2022
Efficacy Evaluation of Zoledronic Acid Combined with Chemotherapy in the Treatment of Lung Cancer Spinal Metastases on Computed Tomography Images on Intelligent Algorithms. Computational and mathematical methods in medicine, 2022, Volume: 2022 Topics: Algorithms; Alopecia; Bayes Theorem; Bone Neoplasms; Cisplatin; Disease Progression; Humans; Lung Neoplasms; Pain; Spinal Neoplasms; Tomography, X-Ray Computed; Treatment Outcome; Zoledronic Acid	2022
Proinflammatory reaction to a bisphosphonate infusion in a patient with a reverse shoulder replacement and literature review. BMJ case reports, 2022, Oct-12, Volume: 15, Issue:10 Topics: Arthroplasty, Replacement, Shoulder; Bone Density Conservation Agents; Diphosphonates; Female; Humans; Imidazoles; Pain; Zoledronic Acid	2022
Retrospective assessment of tolerability and efficacy of zoledronate in the palliative treatment of cancer-bearing dogs. Australian veterinary journal, 2023, Volume: 101, Issue:1-2 Topics: Animals; Calcium; Dog Diseases; Dogs; Hypercalcemia; Neoplasms; Pain; Palliative Care; Retrospective Studies; Zoledronic Acid	2023
Bisphosphonate treatment in inaccessible osteoid osteomas: An alternative therapeutic approach. Joint bone spine, 2023, Volume: 90, Issue:6 Topics: Adult; Bone Neoplasms; Diphosphonates; Humans; Male; Osteoma, Osteoid; Pain; Treatment Outcome; Zoledronic Acid	2023
Medication-related osteonecrosis of the jaw in a patient with multiple myeloma: an unusual case with tumor in the surgical specimen. Oral radiology, 2022, Volume: 38, Issue:2 Topics: Aged; Bisphosphonate-Associated Osteonecrosis of the Jaw; Diphosphonates; Female; Humans; Multiple Myeloma; Pain; Zoledronic Acid	2022
Multicenter Study on Observation of Acute-phase Responses After Infusion of Zoledronic Acid 5 mg in Chinese Women with Postmenopausal Osteoporosis. Orthopaedic surgery, 2017, Volume: 9, Issue:3 Topics: Acute-Phase Reaction; Aged; Anti-Inflammatory Agents, Non-Steroidal; Bone Density Conservation Agents; China; Diphosphonates; Female; Humans; Imidazoles; Incidence; Infusions, Intravenous; Middle Aged; Osteoporosis, Postmenopausal; Pain; Product Surveillance, Postmarketing; Zoledronic Acid	2017
Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update Summary. Journal of oncology practice, 2017, Volume: 13, Issue:12 Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Denosumab; Female; Humans; Medical Oncology; Ontario; Pain; Pamidronate; Societies, Medical; United States; Zoledronic Acid	2017
Contribution of Inflammation and Bone Destruction to Pain in Arthritis: A Study in Murine Glucose-6-Phosphate Isomerase-Induced Arthritis. Arthritis & rheumatology (Hoboken, N.J.), 2019, Volume: 71, Issue:12 Topics: Activating Transcription Factor 3; Animals; Arthritis, Experimental; Arthritis, Rheumatoid; Bone Resorption; Cyclic AMP Response Element-Binding Protein; Glucose-6-Phosphate Isomerase; Hindlimb; Hyperalgesia; Inflammation; Mice; Pain; T-Lymphocytes, Regulatory; TRPV Cation Channels; Zoledronic Acid	2019
Jaw lesion and discomfort. JAMA, 2013, Nov-27, Volume: 310, Issue:20 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Carcinoma, Renal Cell; Chlorhexidine; Diphosphonates; Doxycycline; Female; Gingival Diseases; Humans; Imidazoles; Kidney Neoplasms; Mandible; Middle Aged; Mouthwashes; Oral Hygiene; Pain; Zoledronic Acid	2013
Patients' preferences for bone metastases treatments in France, Germany and the United Kingdom. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2015, Volume: 23, Issue:1 Topics: Adult; Antibodies, Monoclonal, Humanized; Bone and Bones; Bone Density Conservation Agents; Bone Neoplasms; Choice Behavior; Denosumab; Diphosphonates; Female; France; Germany; Humans; Imidazoles; Kidney Diseases; Male; Middle Aged; Osteonecrosis; Pain; Patient Participation; Patient Preference; RANK Ligand; Treatment Outcome; United Kingdom; Zoledronic Acid	2015
Prospective Evaluation of Zoledronic Acid in the Treatment of Bone Metastases from Differentiated Thyroid Carcinoma. Annals of surgical oncology, 2015, Volume: 22, Issue:12 Topics: Adult; Aged; Alkaline Phosphatase; Antineoplastic Agents; Biomarkers, Tumor; Bone Neoplasms; Carcinoma; Collagen Type I; Diphosphonates; Disease Progression; Female; Humans; Imidazoles; Male; Middle Aged; Pain; Peptides; Prospective Studies; Response Evaluation Criteria in Solid Tumors; Spinal Cord Compression; Thyroid Neoplasms; Zoledronic Acid	2015
Urinary N telopeptide levels in predicting the anti-nociceptive responses of zoledronic acid and paclitaxel in a rat model of bone metastases. Molecular medicine reports, 2015, Volume: 12, Issue:3 Topics: Acid Sensing Ion Channels; Analgesics; Animals; Biomarkers; Bone Neoplasms; Cell Line, Tumor; Collagen Type I; Diphosphonates; Drug Evaluation, Preclinical; Female; Ganglia, Spinal; Hyperalgesia; Imidazoles; Neoplasm Transplantation; Osteoclasts; Paclitaxel; Pain; Peptides; Proto-Oncogene Proteins c-fos; Rats, Wistar; Spinal Cord; Zoledronic Acid	2015
Use of intravenous bisphosphonates in older women with breast cancer. The oncologist, 2008, Volume: 13, Issue:5 Topics: Age Factors; Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Cohort Studies; Diphosphonates; Female; Follow-Up Studies; Fractures, Bone; Humans; Imidazoles; Injections, Intravenous; Multivariate Analysis; Pain; Pamidronate; Prevalence; SEER Program; Survival Rate; United States; Zoledronic Acid	2008
Effect of zoledronic acid on bone pain secondary to metastatic bone disease. Medicine and health, Rhode Island, 2009, Volume: 92, Issue:1 Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Humans; Imidazoles; Male; Middle Aged; Pain; Zoledronic Acid	2009
The impact of zoledronic acid therapy in survival of lung cancer patients with bone metastasis. International journal of cancer, 2009, Oct-01, Volume: 125, Issue:7 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Non-Small-Cell Lung; Diphosphonates; Disease Progression; Drug Administration Schedule; Female; Humans; Imidazoles; Kaplan-Meier Estimate; Lung Neoplasms; Male; Middle Aged; Pain; Proportional Hazards Models; Treatment Outcome; Zoledronic Acid	2009
Treatment of painful bone metastases in hormone-refractory prostate cancer with zoledronic acid and samarium-153-ethylenediaminetetramethylphosphonic acid combined. Journal of palliative medicine, 2009, Volume: 12, Issue:7 Topics: Aged; Analgesics, Non-Narcotic; Bone Density Conservation Agents; Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Humans; Imidazoles; Male; Organometallic Compounds; Organophosphorus Compounds; Pain; Prostatic Neoplasms; Radiopharmaceuticals; Zoledronic Acid	2009
Management of metastatic bone pain with repeated doses of rhenium 186-HEDP in patients under therapy with zoledronic acid: a safe and additively effective practice. Cancer biotherapy & radiopharmaceuticals, 2009, Volume: 24, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Analgesics; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Etidronic Acid; Female; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Organometallic Compounds; Pain; Pain Measurement; Prostatic Neoplasms; Treatment Outcome; Zoledronic Acid	2009
Prognostic factors for skeletal complications from metastatic bone disease in breast cancer. Breast cancer research and treatment, 2010, Volume: 123, Issue:3 Topics: Aged; Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Clinical Trials, Phase III as Topic; Diphosphonates; Female; Fractures, Bone; Humans; Imidazoles; Middle Aged; Multicenter Studies as Topic; Pain; Pain Measurement; Proportional Hazards Models; Randomized Controlled Trials as Topic; Retrospective Studies; Risk Assessment; Risk Factors; Spinal Cord Compression; Spinal Fractures; Treatment Outcome; Zoledronic Acid	2010
Inhibition of osteoclasts prevents cartilage loss and pain in a rat model of degenerative joint disease. Osteoarthritis and cartilage, 2010, Volume: 18, Issue:10 Topics: Animals; Arthritis, Experimental; Bone Density; Bone Density Conservation Agents; Cartilage, Articular; Diphosphonates; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Imidazoles; Iodoacetates; Male; Osteoarthritis; Osteoclasts; Pain; Rats; Rats, Sprague-Dawley; Zoledronic Acid	2010
Bisphosphonates for bone pain #113. Journal of palliative medicine, 2010, Volume: 13, Issue:7 Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Neoplasms; Pain; Pamidronate; Renal Insufficiency; Zoledronic Acid	2010
Predicting skeletal complications in metastatic breast cancer raises challenges. Breast cancer research and treatment, 2010, Volume: 123, Issue:3 Topics: Antineoplastic Agents; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Fractures, Bone; Humans; Imidazoles; Pain; Risk Assessment; Risk Factors; Spinal Cord Compression; Spinal Fractures; Treatment Outcome; Zoledronic Acid	2010
Treatment of Langerhans cell histiocytosis bone lesions with zoledronic acid: a case series. International journal of hematology, 2011, Volume: 93, Issue:6 Topics: Adult; Bone and Bones; Bone Density Conservation Agents; Bone Diseases; Diphosphonates; Female; Histiocytosis, Langerhans-Cell; Humans; Imidazoles; Male; Pain; Radiography; Treatment Outcome; Young Adult; Zoledronic Acid	2011
Efficacy of zoledronic acid in treatment of teoarthritis is dependent on the disease progression stage in rat medial meniscal tear model. Acta pharmacologica Sinica, 2012, Volume: 33, Issue:7 Topics: Animals; Bone Density Conservation Agents; Bone Remodeling; Calcitonin Gene-Related Peptide; Cartilage, Articular; Diphosphonates; Gene Expression; Imidazoles; Male; Osteoarthritis, Knee; Pain; Rats; Rats, Sprague-Dawley; Zoledronic Acid	2012
[Bisphosphonates in bone metastases. Fewer fractures, less pain]. MMW Fortschritte der Medizin, 2002, Sep-26, Volume: 144, Issue:39 Topics: Bone Neoplasms; Clinical Trials as Topic; Diphosphonates; Fractures, Spontaneous; Humans; Imidazoles; Infusions, Intravenous; Pain; Pamidronate; Zoledronic Acid	2002
Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain. Pain, 2002, Volume: 100, Issue:3 Topics: Animals; Bone Density; Bone Neoplasms; Clodronic Acid; Diphosphonates; Female; Hyperalgesia; Hyperesthesia; Imidazoles; Models, Animal; Neoplasm Transplantation; Observer Variation; Pain; Pain Measurement; Pain Threshold; Pamidronate; Radiography; Rats; Rats, Sprague-Dawley; Reference Values; Reproducibility of Results; Sensitivity and Specificity; Tibia; Touch; Treatment Outcome; Zoledronic Acid	2002
Short-term safety assessment in the use of intravenous zoledronic acid in children. The Journal of pediatrics, 2004, Volume: 145, Issue:5 Topics: Adolescent; Bone Resorption; Calcium; Child; Child, Preschool; Creatinine; Diphosphonates; Female; Fever; Follow-Up Studies; Humans; Imidazoles; Infusions, Intravenous; Male; Nausea; Pain; Phosphorus; Retrospective Studies; Time Factors; Urea; Vomiting; Zoledronic Acid	2004
Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. Journal of the National Cancer Institute, 2005, Jan-05, Volume: 97, Issue:1 Topics: Analgesics; Antineoplastic Agents; Bone Neoplasms; Diphosphonates; Fractures, Bone; Humans; Imidazoles; Jaw; Male; Necrosis; Osteomyelitis; Osteopetrosis; Pain; Pain Measurement; Pamidronate; Prostatic Neoplasms; Quality of Life; Research Design; Surveys and Questionnaires; Time Factors; Treatment Outcome; Zoledronic Acid	2005
Combination of docetaxel, estramustine phosphate, and zoledronic acid in androgen-independent metastatic prostate cancer: efficacy, safety, and clinical benefit assessment. Urology, 2005, Volume: 65, Issue:1 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Alopecia; Androgen Antagonists; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Disease Progression; Disease-Free Survival; Docetaxel; Drug Resistance, Neoplasm; Estramustine; Humans; Imidazoles; Life Tables; Liver Neoplasms; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Proteins; Neutropenia; Orchiectomy; Pain; Palliative Care; Prostate-Specific Antigen; Prostatic Neoplasms; Radiotherapy, High-Energy; Remission Induction; Survival Analysis; Taxoids; Treatment Outcome; Zoledronic Acid	2005
Zoledronic acid-induced severe hypocalcaemia in a prostate cancer patient with extensive osteoblastic bone metastases. Tennessee medicine : journal of the Tennessee Medical Association, 2005, Volume: 98, Issue:2 Topics: Adenocarcinoma; Aged; Bone Neoplasms; Bone Resorption; Diphosphonates; Humans; Hypocalcemia; Imidazoles; Male; Pain; Prostatic Neoplasms; Zoledronic Acid	2005
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases. Bone, 2006, Volume: 39, Issue:1 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Diphosphonates; Female; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Neoplasm Metastasis; Pain; Palliative Care; Prostatic Neoplasms; Strontium Radioisotopes; Time Factors; Treatment Outcome; Zoledronic Acid	2006
Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Mar-20, Volume: 24, Issue:9 Topics: Aged; Bone Density Conservation Agents; Bone Neoplasms; Carcinoma, Renal Cell; Diphosphonates; Humans; Hyperbaric Oxygenation; Imidazoles; Jaw; Kidney Neoplasms; Male; Osteonecrosis; Pain; Zoledronic Acid	2006
Home infusions of biphosphonate in cancer patients: a prospective study. Journal of chemotherapy (Florence, Italy), 2006, Volume: 18, Issue:2 Topics: Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Home Infusion Therapy; Humans; Imidazoles; Infusions, Intravenous; Male; Middle Aged; Pain; Patient Acceptance of Health Care; Patient Compliance; Patient Satisfaction; Prospective Studies; Treatment Outcome; Zoledronic Acid	2006
Zoledronic acid palliation in bone-metastatic breast cancer. The Lancet. Oncology, 2006, Volume: 7, Issue:11 Topics: Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Clinical Trials, Phase II as Topic; Diphosphonates; Female; Humans; Imidazoles; Pain; Zoledronic Acid	2006
Management of pain in elderly patients receiving infusion of zoledronic acid for bone metastasis: a single-institution report. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2008, Volume: 16, Issue:2 Topics: Aged; Aged, 80 and over; Bone Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Male; Pain; Pain Measurement; Quality of Life; Surveys and Questionnaires; Treatment Outcome; Zoledronic Acid	2008
Role of the nurse in preserving patients' independence. European journal of oncology nursing : the official journal of European Oncology Nursing Society, 2007, Volume: 11 Suppl 2 Topics: Activities of Daily Living; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Documentation; Drug Monitoring; Humans; Hypercalcemia; Imidazoles; Nurse's Role; Nursing Assessment; Nursing Records; Oncology Nursing; Pain; Patient Compliance; Patient Education as Topic; Social Support; Treatment Outcome; Zoledronic Acid	2007